FDAFDA · Food and drugs·Recall number D-0866-2026
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
Published September 23, 2026 · Recall initiated: August 21, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent Drug
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- THYROID
- Manufacturer
- VITRUVIAS THERAPEUTICS INC
- Distributor
- US Nationwide.
- Lot
- Lot # 504950, Exp Date: 09/30/2026.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.
Recalert also tracks expiration dates so you can sell stock before it becomes a loss.